摘要
目的 了解新疆地区四地州苯丙酮尿症(PKU)患者低/无苯丙氨酸特殊医学用途配方食品(以下简称特食)治疗随访依从性的影响因素,为规范PKU患者的随访,保证特食治疗效果提供依据。方法 调查2010年1月—2020年12月在乌鲁木齐市妇幼保健院治疗随访≥1年以上的PKU患者,对其照护人进行访谈、问卷调查,收集整理PKU患者特食治疗现状,分析特食治疗随访依从性的影响因素。结果 不同筛查情况,接受过新生儿疾病筛查、新生儿基因确诊、母亲孕期唐氏筛查检查的患者依从性较好,差异有统计学意义(χ^(2)=5.753、10.993、9.189,P<0.05)。不同家庭情况,父母亲文化程度为大专及以上者PKU患者的特食治疗依从性较高,差异有统计学意义(χ^(2)=8.321、7.415,P<0.05);父母亲有固定职业的家庭其依从性较高,差异有统计学意义(χ^(2)=20.626、7.895,P<0.05)。年龄、购买特食的间隔时间、送检血片的次数、正常年龄入学情况(χ^(2)=19.443、8.090、69.482、12.001,P<0.05)对PKU患者特食治疗随访依从性存在影响。结论 PKU是一种可以治疗的遗传代谢性疾病,结合临床实际加强健康宣教,制订规范的随访方案及流程,提升随访治疗依从性,为提高PKU患者治疗随访成效起到重要作用。
Objective To investigate the influencing factors behind the follow-up compliance of patients with low/no phenylketonuria(PKU) for special medical use, in order to provide a basis for regulating the follow-up of PKU patients and ensuring the effectiveness of special diet treatment. Methods A survey was conducted on PKU patients treated in Urumqi Maternal and Child Health Hospital for over 1 year, from January 2010 to December 2020. Interviews and questionnaires were conducted with their caregivers to collect and analyze the current status of PKU patients undergoing special diet treatment, and to identify the influencing factors behind their compliance with follow-up treatment. Results Patients who had received neonatal disease screening, neonatal gene diagnosis, and maternal Down′s screening during pregnancy had better compliance, with statistically significant differences(χ^(2)=5.753, 10.993, 9.189, P<0.05). PKU children with parents who had a college education or above showed significantly higher adherence to special diet treatment(χ^(2)=8.321, 7.415, P<0.05). PKU children with parents having a fixed occupation also showed higher compliance, with a statistically significant difference(χ^(2)=20.626, 7.895, P<0.05). Patient age, interval of buying special diet, number of blood samples sent and enrollment of normal age, all had a significant impact on the follow-up compliance of PKU patients with special diet(χ^(2)=19.443, 8.090, 69.482, 12.001, P<0.05). Conclusions PKU is a treatable genetic metabolic disease. Strengthening health education, formulating standardized follow-up plans and procedures, and improving follow-up treatment compliance are crucial in enhancing the treatment and follow-up effectiveness of PKU patients.
作者
周尚琴
陈曦
薛淑媛
张璐涵
丁桂凤
ZHOU Shangqin;CHEN Xi;XUE Shuyuan;ZHANG Luhan;DING Guifeng(School of Nursing,Hexi University,Zhangye,Gansu 734000,China;School of Public Health,Xinjiang Medical University,Urumqi,Xinjiang Uygur Autonomous Region 830000,China;Department of Child Rehabilitation,Urumqi Maternal and Child Health Care Hospital,Urumqi,Xinjiang Uygur Autonomous Region 830000,China;Urumqi Maternal and Child Health Care Hospital Neonatal Disease Screening Center,Urumqi,Xinjiang Uygur Autonomous Region 830000,China;Department of Science and Education,Urumqi Maternal and Child Health Care Hospital,Urumqi,Xinjiang Uygur Autonomous Region 830000,China;Department of Obstetrics,Urumqi Maternal and Child Health Hospital,Urumqi,Xinjiang Uygur Autonomous Region 830000,China)
出处
《中国儿童保健杂志》
CAS
CSCD
北大核心
2024年第2期191-195,207,共6页
Chinese Journal of Child Health Care
